Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
52 hedge funds and large institutions have $119M invested in Global Cord Blood Corporation in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 12 closing their positions.
83% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 12
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
32% more capital invested
Capital invested by funds: $90.4M → $119M (+$29.1M)
21% more funds holding
Funds holding: 43 → 52 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$8.83M |
| 2 |
Renaissance Technologies
New York
|
+$5.33M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.09M |
| 4 |
PM
Parametrica Management
Wanchai,
Hong Kong
|
+$3.39M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$3.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GP
GLG Partners
London,
United Kingdom
|
-$9.85M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$8.63M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.19M |
| 4 |
SIM
Spark Investment Management
New York
|
-$1.09M |
| 5 |
Citigroup
New York
|
-$580K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Simplex Trading
Chicago,
Illinois
| $3K | +$3.59K | +307 | New |
|
|
SIM
52
Spark Investment Management
New York
| – | -$1.09M | -114,800 | Closed |
|
|
53
Citigroup
New York
| – | -$580K | -61,175 | Closed |
|
|
BIP
54
Brandes Investment Partners
La Jolla,
California
| – | -$375K | -39,542 | Closed |
|
55
Citadel Advisors
Miami,
Florida
| – | -$208K | -21,973 | Closed |
|
56
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$95K | -10,000 | Closed |
|
57
UBS Group
Zurich,
Switzerland
| – | -$55K | -5,739 | Closed |
|
|
OTC
58
Opera Trading Capital
Paris,
France
| – | -$45K | -4,790 | Closed |
|
59
Russell Investments Group
London,
United Kingdom
| – | -$35K | -3,654 | Closed |
|
|
AIM
60
Acrospire Investment Management
Chicago,
Illinois
| – | -$27K | -2,835 | Closed |
|
61
Barclays
London,
United Kingdom
| – | -$19K | -2,000 | Closed |
|
62
Creative Planning
Overland Park,
Kansas
| – | -$4K | -400 | Closed |
|
|
FMA
63
FNY Managed Accounts
New York
| – | -$3K | -350 | Closed |
|
|
AG
64
Advisor Group
Phoenix,
Arizona
| – | +$316 | +27 | New |
|
CO Hedge Fund Activity: Q3 2017 in Review
52 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2017, worth a combined $119M — up 32% from $90.4M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CO positions and 12 closed out — a net gain of 10 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was Lazard Asset Management, adding an estimated $8.83M. The largest seller was GLG Partners, cutting an estimated $9.85M.
- 52 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2017, up from 43 in Q2 2017.
- Funds reported $119M of Global Cord Blood Corporation stock for Q3 2017, up 32% quarter-over-quarter.
- 22 funds opened new Global Cord Blood Corporation positions in Q3 2017 and 12 closed out, a net change of +10 holders.
- The largest Global Cord Blood Corporation buyer in Q3 2017 was Lazard Asset Management, an estimated $8.83M added.
- The largest Global Cord Blood Corporation seller in Q3 2017 was GLG Partners, an estimated $9.85M sold.
Based on aggregated 13F filings for Q3 2017.